{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:13:28Z","timestamp":1788178408551,"version":"build-2803163510"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijoms.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijom.2026.08.027","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:13:37Z","timestamp":1788174817000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three current approaches to preclinical oral squamous cell carcinoma research: a practical, stepwise framework integrating cell lines, organoids, and animal models"],"prefix":"10.1016","author":[{"given":"T.","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2026.08.027_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijom.2026.08.027_bib2","article-title":"Oral cancer: recent breakthroughs in pathology and therapeutic approaches","volume":"12","author":"Ramachandran","year":"2024","journal-title":"Oral Oncol Rep"},{"key":"10.1016\/j.ijom.2026.08.027_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: state of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.ijom.2026.08.027_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.oraloncology.2019.02.001","article-title":"Survival outcomes after treatment of cancer of the oral cavity (1985\u20132015)","volume":"90","author":"Zanoni","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110107","article-title":"Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohort","volume":"192","author":"Frank","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1186\/s12903-024-04690-z","article-title":"Comprehensive survival analysis of oral squamous cell carcinoma patients undergoing initial radical surgery","volume":"24","author":"Dong","year":"2024","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.ijom.2026.08.027_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.3910","article-title":"Geographic disparities in oral cancer survival from 10 population-based cancer registries in India","volume":"8","author":"Sathishkumar","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijom.2026.08.027_bib8","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.4317\/medoral.26047","article-title":"Epidemiological, clinical, and prognostic analysis of oral squamous cell carcinoma diagnosed and treated in a single hospital in Galicia (Spain): a retrospective study with 5-year follow-up","volume":"29","author":"Amezaga-Fernandez","year":"2024","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.ijom.2026.08.027_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40902-024-00410-3","article-title":"Prognostic factors of oral squamous cell carcinoma: the importance of recurrence and pTNM stage","volume":"46","author":"Kim","year":"2024","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"10.1016\/j.ijom.2026.08.027_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41199-018-0036-6","article-title":"Survival and associated factors among patients with oral squamous cell carcinoma (OSCC) in Mulago Hospital, Kampala, Uganda","volume":"3","author":"Asio","year":"2018","journal-title":"Cancers Head Neck"},{"key":"10.1016\/j.ijom.2026.08.027_bib11","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/ijc.33352","article-title":"Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: challenges and opportunities","volume":"148","author":"Ling","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijom.2026.08.027_bib12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/modpathol.2017.183","article-title":"The histologic risk model is a useful and inexpensive tool to assess risk of recurrence and death in stage I or II squamous cell carcinoma of tongue and floor of mouth","volume":"31","author":"Sinha","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ijom.2026.08.027_bib13","article-title":"The occult nodal metastasis rate of early tongue cancer (T1\u2013T2): a protocol for a systematic review and meta-analysis","volume":"100","author":"Choi","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.ijom.2026.08.027_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2025.107601","article-title":"Clinical and oncological outcome in locoregional advanced oral squamous cell carcinoma treated by primary chemoradiation","volume":"168","author":"Mrosk","year":"2025","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib15","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1038\/s41598-021-84704-w","article-title":"Risk factors for distant metastasis in locoregionally controlled oral squamous cell carcinoma: a retrospective study","volume":"11","author":"Tomioka","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijom.2026.08.027_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10565-025-10048-0","article-title":"Oral squamous cell carcinoma: insights into cellular heterogeneity, drug resistance, and evolutionary trajectories","volume":"41","author":"Zhou","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.ijom.2026.08.027_bib17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41416-023-02186-1","article-title":"Preclinical models in head and neck squamous cell carcinoma","volume":"128","author":"Chaves","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijom.2026.08.027_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57761","article-title":"Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway","volume":"9","author":"Chai","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ijom.2026.08.027_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202936","article-title":"Recent advances on cell culture platforms for in vitro drug screening and cell therapies: from conventional to microfluidic strategies","volume":"12","author":"Cardoso","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ijom.2026.08.027_bib20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.stem.2023.05.012","article-title":"Organoid cultures for cancer modeling","volume":"30","author":"Yan","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijom.2026.08.027_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1629683","article-title":"Integrative multi-omics analysis and experimental validation identify molecular subtypes, prognostic signature, and CA9 as a therapeutic target in oral squamous cell carcinoma","volume":"13","author":"Zhao","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ijom.2026.08.027_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12935-025-03913-9","article-title":"Identification of novel biomarkers involved in oral squamous cell carcinoma by whole transcriptome sequencing and bioinformatics analysis","volume":"25","author":"Du","year":"2025","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ijom.2026.08.027_bib23","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3390\/biomedicines12102373","article-title":"Development and characterization of a three-dimensional organotypic in vitro oral cancer model with four co-cultured cell types, including patient-derived cancer-associated fibroblasts","volume":"12","author":"Aizawa","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijom.2026.08.027_bib24","article-title":"Autophagy and extracellular vesicles mediate cisplatin resistance in oral squamous cell carcinoma with LC3B-II as a potential non-invasive biomarker","volume":"15","author":"Su","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijom.2026.08.027_bib25","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/cells14171311","article-title":"Generation and characterization of cisplatin-resistant oral squamous cell carcinoma cells displaying an epithelial\u2013mesenchymal transition signature","volume":"14","author":"de Morais","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ijom.2026.08.027_bib26","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ccell.2021.07.020","article-title":"Tumor organoids: opportunities and challenges to guide precision medicine","volume":"39","author":"Veninga","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijom.2026.08.027_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.medj.2023.04.003","article-title":"Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification","volume":"4","author":"Millen","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib28","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1186\/s12967-024-05824-1","article-title":"Advancing cancer research through organoid technology","volume":"22","author":"Zeng","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib29","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ijom.2026.08.027_bib30","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1038\/s41467-022-30722-9","article-title":"The drug-induced phenotypic landscape of colorectal cancer organoids","volume":"13","author":"Betge","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijom.2026.08.027_bib31","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","article-title":"Oral mucosal organoids as a potential platform for personalized cancer therapy","volume":"9","author":"Driehuis","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijom.2026.08.027_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12105-024-01658-x","article-title":"Clinicopathological factors as predictors for establishment of patient derived head and neck squamous cell carcinoma organoids","volume":"18","author":"de Kort","year":"2024","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.ijom.2026.08.027_bib33","article-title":"Organoid co-culture models of the tumor microenvironment promote precision medicine","volume":"3","author":"Gu","year":"2023","journal-title":"Cancer Innov"},{"key":"10.1016\/j.ijom.2026.08.027_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0022034520956614","article-title":"3D co-culture of cancer-associated fibroblast with oral cancer organoids","volume":"100","author":"Zhao","year":"2021","journal-title":"J Dent Res"},{"key":"10.1016\/j.ijom.2026.08.027_bib35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/s41388-023-02642-5","article-title":"Stromal nicotinamide N-methyltransferase orchestrates the crosstalk between fibroblasts and tumour cells in oral squamous cell carcinoma: evidence from patient-derived assembled organoids","volume":"42","author":"Zhao","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ijom.2026.08.027_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1186\/s12967-023-04650-1","article-title":"Changes of immune microenvironment in head and neck squamous cell carcinoma in 3D-4-culture compared to 2D-4-culture","volume":"21","author":"Xiao","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib37","first-page":"263","article-title":"Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): new opportunities in establishing faithful pre-clinical cancer models","volume":"2","author":"Wang","year":"2022","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.ijom.2026.08.027_bib38","article-title":"Modeling methods of different tumor organoids and their application in tumor drug resistance research","volume":"8","author":"Yang","year":"2025","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.ijom.2026.08.027_bib39","article-title":"Organoid models for precision cancer immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijom.2026.08.027_bib40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s44222-023-00089-7","article-title":"Computational approaches to modelling and optimizing cancer treatment","volume":"1","author":"McDonald","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.ijom.2026.08.027_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-022-03405-8","article-title":"Patient-derived xenograft (PDX) models, applications and challenges in cancer research","volume":"20","author":"Abdolahi","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108631","article-title":"Orthotopic and metastatic tumour models in preclinical cancer research","volume":"257","author":"Stribbling","year":"2024","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ijom.2026.08.027_bib43","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/s41388-023-02783-7","article-title":"Genetically engineered mouse models of head and neck cancers","volume":"42","author":"Tasoulas","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ijom.2026.08.027_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fonc.2020.00212","article-title":"Mouse tumor-bearing models as preclinical study platforms for oral squamous cell carcinoma","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.oraloncology.2015.01.012","article-title":"Orthotopic non-metastatic and metastatic oral cancer mouse models","volume":"51","author":"Bais","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib46","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.3390\/ijms23169195","article-title":"Mouse models for immune checkpoint blockade therapeutic research in oral cancer","volume":"23","author":"Chiu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijom.2026.08.027_bib47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12967-023-04221-4","article-title":"HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies","volume":"21","author":"Modic","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib48","first-page":"1501","article-title":"An HNSCC syngeneic mouse model for tumor immunology research and preclinical evaluation","volume":"46","author":"Fu","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib49","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc.2016.140","article-title":"Interrogating open issues in cancer precision medicine with patient-derived xenografts","volume":"17","author":"Byrne","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijom.2026.08.027_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.792297","article-title":"Genomic and molecular signatures of successful patient-derived xenografts for oral cavity squamous cell carcinoma","volume":"12","author":"Yen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3892\/ol.2022.13502","article-title":"Investigation of bone invasion and underlying mechanisms of oral cancer using a cell line-derived xenograft model","volume":"24","author":"Shan","year":"2022","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ijom.2026.08.027_bib52","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1038\/s41467-022-31859-3","article-title":"A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer","volume":"13","author":"Goldberg","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijom.2026.08.027_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1343839","article-title":"4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment","volume":"14","author":"Sell\u00e6g","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib54","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/2326-6066.CIR-23-0133","article-title":"Genomic and transcriptomic landscape of an oral squamous cell carcinoma mouse model for immunotherapy","volume":"11","author":"Lee","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijom.2026.08.027_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.mcb.2025.03.023","article-title":"Orthotopic model of tongue cancer for the study of head and neck squamous cell carcinoma in mice","volume":"197","author":"Scuderi","year":"2025","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.ijom.2026.08.027_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277239","article-title":"CT vs. bioluminescence: a comparison of imaging techniques for orthotopic prostate tumors in mice","volume":"17","author":"Myers","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijom.2026.08.027_bib57","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","article-title":"A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology","volume":"3","author":"Guillen","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ijom.2026.08.027_bib58","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","article-title":"Patient-derived xenograft models in cancer therapy: technologies and applications","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ijom.2026.08.027_bib59","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ng.3967","article-title":"Patient-derived xenografts undergo mouse-specific tumor evolution","volume":"49","author":"Ben-David","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijom.2026.08.027_bib60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2767-9764.CRC-22-0431","article-title":"Mouse stromal cells confound proteomic characterization and quantification of xenograft models","volume":"3","author":"Shi","year":"2023","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.ijom.2026.08.027_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2382531","article-title":"Establishment of a visualized mouse orthotopic xenograft model of nasopharyngeal carcinoma","volume":"25","author":"Chen","year":"2024","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ijom.2026.08.027_bib62","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1111\/febs.70216","article-title":"A patient-derived orthotopic xenograft model unveils metastatic dynamics in head and neck squamous cell carcinoma","volume":"292","author":"Bai","year":"2025","journal-title":"FEBS J"},{"key":"10.1016\/j.ijom.2026.08.027_bib63","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/1878-0261.70026","article-title":"Interplay of integrins and selectins in metastasis","volume":"19","author":"Maltseva","year":"2025","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.34172\/aim.2024.24","article-title":"The confounding role of graft-versus-host disease in animal models of cancer immunotherapy: a systematic review","volume":"27","author":"Ashraf","year":"2024","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.852","article-title":"Humanized mouse models for immuno-oncology drug discovery","volume":"3","author":"Kumari","year":"2023","journal-title":"Curr Protoc"},{"key":"10.1016\/j.ijom.2026.08.027_bib66","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1177\/0271678X20943823","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"40","author":"Percie du Sert","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.ijom.2026.08.027_bib67","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1158\/0008-5472.CAN-17-0582","article-title":"PDX-MI: minimal information for patient-derived tumor xenograft models","volume":"77","author":"Meehan","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijom.2026.08.027_bib68","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1038\/s41596-024-00998-w","article-title":"OBSERVE: guidelines for the refinement of rodent cancer models","volume":"19","author":"De Vleeschauwer","year":"2024","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ijom.2026.08.027_bib69","article-title":"Humanized mouse models for immuno-oncology research: a review and implications in lung cancer research","volume":"6","author":"Park","year":"2024","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.ijom.2026.08.027_bib70","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s13402-025-01068-3","article-title":"Trends in immunotherapy for oral squamous cell carcinoma","volume":"48","author":"Xue","year":"2025","journal-title":"Cell Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib71","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.medj.2024.08.010","article-title":"Patient-derived organoids in precision cancer medicine","volume":"5","author":"Tong","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41199-020-00056-4","article-title":"Preclinical models of head and neck squamous cell carcinoma for a basic understanding of cancer biology and its translation into efficient therapies","volume":"5","author":"Tinhofer","year":"2020","journal-title":"Cancers Head Neck"},{"key":"10.1016\/j.ijom.2026.08.027_bib73","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41698-025-01082-6","article-title":"PharmaFormer predicts clinical drug responses through transfer learning guided by patient derived organoid","volume":"9","author":"Zhou","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib74","article-title":"Organoid morphology-guided classification for oral cancer reveals prognosis","volume":"6","author":"Lee","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-025-02321-x","article-title":"Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challenges","volume":"24","author":"Mao","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ijom.2026.08.027_bib76","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00234-024-03485-x","article-title":"Diagnostic accuracy of radiomics and artificial intelligence models in diagnosing lymph node metastasis in head and neck cancers: a systematic review and meta-analysis","volume":"67","author":"Valizadeh","year":"2025","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ijom.2026.08.027_bib77","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12880-024-01444-9","article-title":"Predicting response to immunotherapy in oral squamous cell carcinoma via a CT-based radiomics model","volume":"24","author":"Ma","year":"2024","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.ijom.2026.08.027_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1395159","article-title":"Application of CT and MRI images based on artificial intelligence to predict lymph node metastases in patients with oral squamous cell carcinoma: a subgroup meta-analysis","volume":"14","author":"Deng","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102385","article-title":"Comparing three-dimensional and two-dimensional deep-learning, radiomics, and fusion models for predicting occult lymph node metastasis in laryngeal squamous cell carcinoma based on CT imaging: a multicentre, retrospective, diagnostic study","volume":"67","author":"Wang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijom.2026.08.027_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71137","article-title":"Barcoded orthotopic patient-derived head and neck squamous cell carcinoma model demonstrating clonal stability and maintenance of cancer driver mutational landscape","volume":"14","author":"Zhou","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3135470","article-title":"Establishment and identification of patient-derived xenograft model for oral squamous cell carcinoma","volume":"2022","author":"He","year":"2022","journal-title":"J Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s44178-024-00104-w","article-title":"The techniques and applications of patient-derived head and neck cancer organoids: a systematic review","volume":"4","author":"Xia","year":"2025","journal-title":"Holist Integ Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib83","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.3390\/cancers14215254","article-title":"Quantitative framework for bench-to-bedside cancer research","volume":"14","author":"Zaman","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijom.2026.08.027_bib84","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.3390\/cancers12123743","article-title":"Patient-derived xenograft and organoid models for precision medicine targeting of the tumour microenvironment in head and neck cancer","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ijom.2026.08.027_bib85","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.3390\/cancers15153779","article-title":"The immune cells in the development of oral squamous cell carcinoma","volume":"15","author":"Caponio","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ijom.2026.08.027_bib86","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.7150\/thno.96027","article-title":"Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development","volume":"14","author":"Xiang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ijom.2026.08.027_bib87","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1631\/jzus.B2400052","article-title":"Preclinical models in the study of lymph node metastasis","volume":"26","author":"Wei","year":"2025","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.ijom.2026.08.027_bib88","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3390\/ph17081048","article-title":"The pivotal role of preclinical animal models in anti-cancer drug discovery and personalized cancer therapy strategies","volume":"17","author":"Guo","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijom.2026.08.027_bib89","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40463-017-0234-y","article-title":"Functional and quality of life outcomes after partial glossectomy: a multi-institutional longitudinal study of the head and neck research network","volume":"46","author":"Dzioba","year":"2017","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijom.2026.08.027_bib90","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1158\/0008-5472.CAN-20-0373","article-title":"Preclinical applications of multi-platform imaging in animal models of cancer","volume":"81","author":"Serkova","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijom.2026.08.027_bib91","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","article-title":"Patient-derived organoids as a predictive biomarker for treatment response in cancer patients","volume":"5","author":"Wensink","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ijom.2026.08.027_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijom.2026.08.027_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21159-7","article-title":"Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC","volume":"12","author":"Rabasco Meneghetti","year":"2022","journal-title":"Sci Rep"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502726003644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502726003644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:13:49Z","timestamp":1788174829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502726003644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":93,"alternative-id":["S0901502726003644"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2026.08.027","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three current approaches to preclinical oral squamous cell carcinoma research: a practical, stepwise framework integrating cell lines, organoids, and animal models","name":"articletitle","label":"Article Title"},{"value":"International Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijom.2026.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Association of Oral and Maxillofacial Surgeons.","name":"copyright","label":"Copyright"}]}}